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Abstract
Polymer vesicles (polymersomes) are spherical assemblies with aqueous cores, formed
by the self-assembly o f amphiphilic polymers in an aqueous environment. They resemble
phospholipid vesicles, but typically exhibit much greater stabilities. The chemical versatility of
the polymer synthesis makes it possible to tune the vesicle characteristics such as vesicle size
and: circulation time in vivo. As such, they are highly promising materials for various
applications including drug delivery. Our research group recently developed a versatile approach
for the conjugation o f dendritic groups to the surfaces o f polymer vesicles which allows the
surface properties to be readily tuned for specific biological properties or applications. This
thesis will investigate the effects o f different dendron functionalities, both neutral and cationic,
on the rate o f release of encapsulated small molecules and larger biomacromolecules,
cytotoxicity and the cell uptake properties o f polymer vesicles. These properties were explored
in both non-biodegradable vesicles based on polybutadiene-poly(ethylene oxide) (PBD-PEO)
and biodegradable vesicles based on polycaprolactone-poly(ethylene'oxide) (PEOPCL).

The

rate o f release o f an encapsulated small molecule, rhodamine B, was founk to be dependent on
the absence or presence of dendritic functionality. Unlike with small molecules, the release of
encapsulated protein, bovine serum albumin (BSA), depends on the charge o f the dendritic
functionalization since both cationic systems exhibited faster, similar release profiles.

The

cytotoxicity o f the vesicle systems was found to be dependent on their surface charge as toxicity
was observed with both cationic systems at higher concentrations. Finally, the cell uptake was
.

rv

found to be dependent on the functional group displayed on the vesicle surface and guanidine
functionalized vesicles had significantly increased cell uptake relative to the other samples.
K eyw ords: Polymer Vesicles, Self-assembly, Release, Cytotoxicity, Cell Internalization,
iii
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Part One: Introduction

1.1 Drug Delivery .
Developments in biology and chemistry have led to a wide variety o f therapeutics that are
available to . treat diseases at the cellular level.

Some o f these therapeutics include small

molecules, peptides, proteins, antibodies and nucleic acid derivatives.1 One o f .the largest
hurdles to overcome in treating disease is to deliver a target molecule to the actual target cells,
•y

and then into the target cell past the cell membrane.

To accomplish this, the desired therapeutic

must be able to travel within the blood stream, which is composed primarily o f water. Having
hydrophilic characteristics is advantageous for traveling in the bloodstream but once the
therapeutic reaches its desired site it must also pass the cell membrane. The cell membrane is
hydrophobic in nature and hydrophilic molecules encounter challenges in passing through the
membrane unless there is an active uptake pathway.

Hydrophobic molecules; such as

cholesterol, can move freely in cell membranes but have poor water solubility.

An ideal

therapeutic must exhibit a balance between hydrophobicity and hydrophilicity.

’ ;;

In addition to an inability to cross the cell membrane, short circulation times in the blood,
.
, .• ,■■ . .
.
,
\ ..
....:
undesired rapid biodegradation o f biomolecules, and lack o f specificity for the therapeutic target
are also common limitations of drug candidates. New nanoscale delivery systems allow for
delivery o f therapeutics in a form in which they are physically protected from degradation by the
body, and may exhibit increased circulation time, targeted delivery to decrease potential harmful
i
side effects and finally, provide a controlled release mechanism o f delivery.
1.2 The Cell Membrane
The. cell membrane has evolved to protect the cell from the exterior environment and to
retain essential molecules within the cell.4 The membrane is selectively permeable to ions, such
as sodium and potassium, and to small molecules such as water, which pass through via
2

f

transporter-proteins. The cell membrane is composed primarily o f a phospholipid bilayer with
j
proteins and glycoproteins imbedded in the bilayer, as shown in Figure 1. Glycoproteins are
t

■

.

.

.

.

composed o f a globular protein which has undergone a post-translational modification to be
covalently bound to a sugar backbone. These proteins are involved in cellular signaling, cell-cell
interactions and provide a scaffold for targeting.

The cell membrane is involved in several

pathways within the cell to facilitate survival activities such as cell adhesion and cell signaling.
Recycling o f the cell membrane is an essential process which is accomplished by two
complimentary mechanisms, exocytosis and endocytosis.5

Exocytosis involves fusion of

intracellular vesicles to the surface o f the cell membrane; this provides a mechanism of
excreting/removing material and installing new proteins on the membrane surface. Endocytosis
3

c

is the reverse o f exocytosis; the process provides the cell with a mechanism *to internalize
molecules in the extracellular matrix that cannot pass through the cell membrane, and removes
proteins from the surface of the membrane. As these processes are dependent on the fluidity of
the membrane, they can be inhibited by decreasing the temperature of'the system. At lower
temperatures, the cell membrane becomes more crystalline and formation o f Vesicles composed
o f a lipid bilayer becomes thermodynamically unfavourable.6

3
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Figure 1. Schematic of the cell membrane.7 The drawing was made by Dana Bums, and can also
be found in Scientific American, 1985, 253(4), pages 100-108, in the article

molecules o f the

cell membrane by M.S. Bretscher.
1.3 Phospholipids and the Phospholipid Bilayer
Comprising the cell membrane, phospholipids are capable of forming a bilayer due to
their amphiphilic structure. Phospholipids are composed of a hydrophilic “head” group with a
phosphate and sometimes other hydrophilic molecules attached to the phosphate group. The
polar head group is attached to the hydrophobic region by a glycerol group. The hydrophobic
“tail” region is composed of two fatty acid chains. In aqueous conditions, the hydrophobic fatty
acid chains align together away from water while the hydrophilic phosphate group is dissolved in
water.
The amphiphilic nature of the phospholipids allows for spontaneous assembly into a
bilayer with the tails aligning, forming a hydrophobic membrane interior, while the hydrophilic
4

heads remain solvated in an aqueous environment. The hydrophobic tail region of the bilayer is
stabilized by hydrophobic interactions between different fatty acid chains. The longer the fatty
O

acid chains in the bilayer, the stronger the interaction.

Furthermore, hydrophobic alignment

prevents water molecules from forming a solvating shell, which decreases the free energy of the
O

system thus making it less thermodynamically favourable.

A common drug delivery system

which utilizes characteristics of the cell membrane is liposomes.9

1.4 Liposomes
Liposomes are composed of synthetic phospholipids which spontaneously assemble into
a vesicle structure, as seen in Figure 2, enabling target drugs to be encapsulated during
assembly.10 Drugs which would be harmful to the body can be encapsulated and delivered
specifically to a target site such as a tumor or diseased tissue, decreasing the toxicity to the body.
There are three different types of liposomes: multilamellar vesicles,11 small unilamellar vesicles
12 and large unilamellar vesicles.13

Furthermore, the surface of the liposome can be

functionalized to produce a targeted liposome.14 Currently, liposome delivery systems are
commercially available including Doxil, Epaxal and Myocet.

Figure 2. Schematic of a liposome, hydrophilic head groups seen in green and hydrophobic tails
in purple.
5

Despite the advantage of being composed of phospholipids commonly found in the cell
membrane, liposomes have several limitations. The small tail region of the phospholipid
molecule impedes the high loading of hydrophobic drugs, limiting liposomes to only load
hydrophilic drugs efficiently.15 Furthermore, the small tail region provides a small hydrophobic
barrier which results in encapsulated drugs within liposomes leaking out quickly, decreasing the
overall efficiency o f delivery.16 Finally, circulation times of liposomes are short as there are
several mechanisms within the body to remove liposomes from the blood.

17

1.5 Block Copolym ers
Block copolymers are composed of a unit of polymerized monomers attached to at least
one other unit o f different polymerized monomers.

Block copolymers are characterized by the

number of blocks they are composed of; a block copolymer consisting of two blocks is called a
diblock copolymer while a copolymer consisting of three blocks in either an ABA or ABC
orientation, where A, B and C are different polymer blocks, is called a triblock copolymer.
Having different polymer units bound together allows for tunability of a polymer of interest, like
thermostability,

elasticity

or solubility.

Copolymers that contain hydrophilic regions and

hydrophobic regions have similar stereoelectronics as phospholipids. As a result, these block
copolymers exhibit self-assembly characteristics.
1.6 Polym er Self-Assembly
Block copolymers that assemble into ordered aggregates in water contain a hydrophilic
block that has a high solubility in water. Poly(ethylene oxide) (PEO) is a common polymer used
as the hydrophilic block.

The volume fraction of the hydrophilic block relative to the

hydrophobic block in the solvent dictates which morphology the assembly will take.

As shown

in Figure 3, generally, if the hydrophilic volume fraction is greater than 50%, a spherical micelle
6

assembly will form. The core of the micelle will be composed of the hydrophobic block of the
copolymer and the exterior shell will be composed of the hydrophilic block.

If the volume

fraction of the hydrophilic block is between 40-50%, a wormlike-micelle will often form with
the core being composed the hydrophobic block and the cylinder shell being composed of the
hydrophilic block. Finally, if the volume fraction of the hydrophilic block is between 25-40% a
vesicle structure with a core composed of the solvent and a shell composed of the hydrophobic
block can form. The hydrophobic monomer unit does not generally influence the morphology
the copolymer will assemble into, rather influences the stability of the assembly.

17

Figure 3. Schematic of block copolymer composition with corresponding assembled structure.

7

1.7 Micelles
Polymeric micelles form from block copolymers that have a hydrophilic volume fraction
greater than 50% relative to the hydrophobic region.

There are several advantages to using

micelles in drug delivery, including dissolution o f hydrophobic drugs and increased circulation
times in the bloodstream. Micelles are capable o f physically entrapping hydrophobic molecules
in the hydrophobic core.18 The entrapped molecules are protected from the external environment
by the hydrophilic corona o f the micelle. Due to this, improvements in drug solubility o f several
orders o f magnitude can be obtained by using micelles relative to direct dissolution.24
Furthermore, as the: hydrophobic drug is protected within the core and away from the blood,
there is less chance o f the drug being metabolized by the body before delivery. The hydrophilic
corona o f micelles are commonly composed o f PEO.25 PEO resists protein adsorption and
cellular adhesion.17

As a result, micelles with a PEO hydrophilic block have an increased

circulation time within the body due to evasion o f hydrolysis, enzymatic degradation and
absorption by the reticuloendothelial system.

Another feature o f polymeric micelles is control

o f the block copolymer used for assembly. The composition o f the block cbpolymer can be
changed to alter degradation time within the body and chain length can be altered to control
'

.,

H

! ' ' '' l ..

diameter o f the micelle as well as the morphology o f the micelle.

More recent advancements in polymeric micelles are to alter the surface topology o f the
micelle.

AM

While a PEO surface layer o f the micelle resists cellular adhesion,

cell-penetrating agent the cellular uptake o f micelles could be increased.

17

by addition of a

Previously, micelle

targeting has depended on a passive targeting technique termed the enhanced permeability and
retention (EPR) effect for delivery to tumour tissues.

This EPR effect results from vasculature

in tumour tissue which has a discontinuous endothelium. As well, the lymphatic drainage system

8

is not completely developed. As a result, assembled polymer systems accumulate in the tissue
around this vasculature system.

Active targeting can be achieved by functionalizing the surface

o f the micelle with a molecule that will bind to cellular receptors on the cell membrane of the
target cell. For example, Chilkoti and coworkers prepared polypeptide micelles that had been
functionalized with the tripeptide targeting group asparagine-glycine-arginine which targets the
transmembrane protein CD 13 which is unregulated in tumour vasculature.

They found that the

functionalized micelles accumulate more in tumour vasculature compared to non-cancerous
tissue. As well, the functionalized micelles accumulate more in tumour vasculature as compared
to unfunctionalized micelles. However, despite their positive results, they claimed their system
was far from optimized.29
Despite all the advantages o f micelles, they are only efficient for delivery o f hydrophobic
drugs. If a charged or hydrophilic drug needs to be delivered to a certain site within the body
another drug delivery system must be employed.
.'s

1.8 Vesicles

\

Polymer vesicles, commonly referred to as polymersomes by analogy with liposomes,
generally form in water from block copolymers with a hydrophilic volume fractions between 2540%.22 Diblock copolymers that assemble into vesicles form a polymeric bilayer that is similar
in orientation to a phospholipid bilayer. Triblock copolymers with an orientation o f ABA where
A is the hydrophilic block and B is the hydrophobic block will form a polymeric monolayer.
Triblock copolymers with a composition o f ABC where A is the hydrophilic block, B is a
hydrophobic block and C is a different hydrophobic block will assemble into vesicles with a
polymeric bilayer similar in orientation to diblock copolymers.

9

1.9 C om parison of Polymer Vesicles and Liposomes
There are both similarities and dissimilarities between polymer vesicles and liposomes.
The two systems are similar in that they are both composed of amphiphiles and both
spontaneously assemble into spherical objects with an aqueous lumen. Furthermore, they both
have a hydrophobic membrane, as seen in Figure 4, which separates the lumen from the
exterior.17 For encapsulated molecules to escape the lumen they must travel through the
hydrophobic region or a pore must open for the molecules to escape. Finally, both have the
potential for the outer layer to be functionalized with a molecule of interest, such as a targeting
group or a cell penetrating agent.

Figure 4. Cross-sectional schematic of liposomes (left) and polymer vesicles (right). Grey
indicates hydrophobic region and light blue indicates hydrophilic region.

10

While liposomes and polymer vesicles both have a defined membrane structure, the
liposome’s hydrophobic region tends to be approximately 3 nm in width while polymer vesicles’
hydrophobic region can exhibit a width from 8-20 nm depending o f the length o f the polymer.

17

The advantage o f having a larger hydrophobic region is that there is a greater loading capacity
for hydrophobic molecules in the membrane as well as a decreased rate o f diffusion through the
membrane for encapsulated hydrophilic molecules.

Moreover, the copolymer used for

assembly can alter characteristics of the vesicle. Stimuli-responsive polymers, which degrade in
response to external cues such as pH or oxidative potential, provide an escape mechanism for
encapsulated hydrophilic molecules in the lumen or hydrophobic molecules. By providing a
release mechanism, polymer vesicles can deliver their cargos to specific sites while keeping nonspecific delivery to a minimum, a characteristic most liposomes do not have.
1.10 Polymer Selection
Since polymer vesicles are desired to be used for drug delivery vehicles, a release
1

*

'x

mechanism from polymer vesicles is advantageous. Hydrophilic cargo within polymer vesicles
are trapped because they cannot readily diffuse through the hydrophobic region of the vesicle
membrane. For that reason, controlling the composition o f the hydrophobic block o f copolymers
so they respond to external stimuli such as pH or oxidative potential is beneficial.

j

Polymer vesicles that are internalized by cells will likely be targeted to the lysosome.

With that in mind, copolymers which respond to acidic environments have become popular.
Incorporation o f 2-(diethyI amino)ethyI methacrylate into the hydrophobic block o f assembling
copolymer allows control over the permeability of the vesicle membrane.

In acidic

environments, like those found in endolysosomes, 2-(diethyl amino)ethyl methacrylate becomes

11

protonated, resulting in a shift from hydrophobic to hydrophilic character. As a result, pores form
in the vesicle membrane which allow for release o f encapsulated cargo.

•31

The endolysosome environment not only has a different pH than the cytoplasm, but also
has a higher oxidative potential.

'X')

•

••

Copolymers which degrade under these conditions would be

advantageous for .targeted release.

Hubbell arid coworkers synthesized a copolymer with a

disulfide bond between the hydrophilic PEO block and the hydrophobic polypropylene sulfide)
block. They report that the resulting vesicles rupture within 10 minutes in the endolysosomal
environment due to cleavage o f the disulfide bond between the hydrophilic and hydrophobic
block.32
While there are mechanisms to induce release from polymer vesicles, new systems are
continually being reported utilizing different parameters such light or temperature.

When

choosing the composition o f copolymers multiple variables must be considered such as
biocompatibility, release mechanism, circulation time and vesicle loading. While composition of
the copolymer is important, it is not the only parameter that needs to be controlled.
1.11 Modes of Vesicle P reparation
Self-assembly o f block copolymers into supramolecular structures usually proceeds
through one o f two methods, either dissolution o f the copolymer into an organic solvent and then
1

•

addition o f water, or dissolution directly into water.

30

The first method, often referred to as

“solvent-switch,” requires the copolymer be dissolved in an organic solvent that is miscible with
water.27 As the copolymer has a large hydrophobic region, it is unlikely that the copolymer can
dissolve directly into water.

Upon the addition o f water, the hydrophobic blocks o f the

copolymer begin to associate with each other in the hydrophilic environment.

However a

drawback of solvent switching is that after assembly the organic solvent has to be removed by
dialysis, which can be time consuming.
The second, direct solution method, involves hydration o f the pure copolymer from a
film.34 To produce a film, the copolymer is often dissolved in an organic solvent and then the
solvent is removed by evaporation. As an organic solvent is usually used, it is not a true organic
solvent free method although there is no mixing between the organic solvent used and water used
in the assembly. Vesicles begin to form upon hydration o f the film. Film rehydration requires
aggressive stirring and longer preparation times as compared to the solvent switch. Furthermore,
this method tends to lead to higher vesicle polydispersities. However, while solvent switch
methods require dialysis to remove remaining organic solvent, organic solvent free methods do
or

not require dialysis.
New methods are being developed for self-assembly to improve loading efficiency but
ultimately use at least one of the above methods in some degree.

For instance, Weitz and
'x

coworkers have developed a method for preparing vesicles with 100% encapsulation efficiency
using a water/oil/water emulsion and a microfluidic device while controlling the size o f the
formed vesicles.36 As well, their model can be applied to form polymer vesicles within polymer
{
37
■
vesicles and higher order polymer vesicle systems.
•

! 1.12 Hydrophilic Drug Loading
Due to the presence o f an aqueous lumen in polymer vesicles, hydrophilic molecules can
be encapsulated.22 Small molecules dissolved in the water used for vesicle preparation will be
encapsulated within the polymer vesicle. The concentration o f small molecules will be the same
inside the vesicle as outside the vesicle; this results from a physical encapsulation of the aqueous
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solution. Non-encapsulated molecules can subsequently be removed by dialysis or another size
based technique. To obtain higher loadings, a thermodynamic driving force must be used, such
as manipulating pH gradients.15 Furthermore, encapsulation of hydrophilic molecules is not
limited to small molecules. Larger molecules, such as proteins, can be encapsulated as shown by
Discher and coworkers.38
The fluorescently labeled insulin is contained completely within the polymer vesicle.
The overlay o f the two channels, red for the polymer membrane and green for insulin, indicates
that the membrane extends further than insulin. Furthermore, the most intense region of the
polymer is at the outer edge, consistent with PKH26 staining the membrane. The insulin does
not overlap with the brightest region, the membrane, suggesting that it is in the lumen and does
not associate with the hydrophobic membrane.
Discher and coworkers showed that other biological macromolecules could be
encapsulated within the lumen o f polymer vesicles.

Short interfering ribonucleic acid (siRNA)

knockdown gene products by initializing cell RNA interference (RNAi) pathways in the cytosol
\ 4 OQ
whereas antisense oligonucleotides alter splicing o f messenger RNA (mRNA) transcripts. To
achieve encapsulation, copolymer dissolved in dimethyl sulphoxide (DMSO) was added to
aqueous solutions o f either FITC-siRNA or FITC-antisense oligonucleotide (AON). Dialysis
¡with a 3.5 KDa molecular weight cut-off (MWCO) membrane was used to remove residual
DMSO followed by dialysis using a 300 KDa MWCO membrane to remove non-encapsulated
material.
Similar to protein encapsulation, both FITC-AON and FITC-siRNA are localized
exclusively within the lumen o f the polymer vesicle since the overlay image deary indicates that
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polymer extends beyond the colocalized region o f the polymer and nucleic acids. In addition, as
the most intense region o f polymer, the membrane, does not show colocalization with the nucleic
acids, it can be concluded that the nucleic acids are in the lumen and do not associate with the
hydrophobic membrane.

:

:

1.13 Hydrophobic Drug Loading
Hydrophobic loading into the polymeric membrane has been previously demonstrated.
However, a drawback was that the hydrophobic model molecule did not have a full hydrophobic
character. Maskos and coworkers showed encapsulation o f a completely hydrophobic dye (Nile
Red) into the membrane o f the vesicle as well as incorporation of quantum dots into the
membrane without changing the size o f the vesicle.40
Furthermore, Discher and coworkers showed encapsulation of a hydrophobic drug,
paclitaxel, and a hydrophilic drug,, doxorubicin, within polymer vesicles.41 The hydrophobic
paclitaxel was sequestered within the polymer membrane while the hydrophilic doxorubicin was
located in the aqueous core of the vesicle. The advantage of having a system with both drugs
encapsulated would be to ensure that the cells which internalize the vesicle would be subjected to
both anticancer agents. As both drugs would be in the cell, there should be higher cytotoxicity as
well as a decreased chance o f the cancerous tissue becoming resistant to one or both drugs.
¡Furthermore, biodegradable copolymers, based on o f polycaprolactone (PCL) and poly(lactic
acid), were incorporated into the polymer vesicles to aid in release o f the drugs from the vesicles
following internalization.
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1.14 In Vitro Analysis
To illustrate their dual drug encapsulation system, Discher and coworkers performed cell
uptake experiments on human breast cancer cells using a biodegradable and non-biodegradable
polymer vesicle system. The results can be seen in Figure TO.
With the biodegradable system, encapsulated doxorubicin was able to leave the vesicle
and concentrate in the nucleus.

The polymer is seen in green and little colocalization was

observed with doxorubicin. By doing so, doxorubicin is available to exert its therapeutic effects
within the cell by ultimately halting the cell cycle and killing the cancerous cell. With the nonbiodegradable system, doxorubicin is colocalized with the polymer vesicle. While in the vesicle
and not in the nucleus, doxorubicin would not be able to exert its effect within the nucleus.
Therefore, the effectiveness of the delivery system is limited by the release o f the encapsulated
cargo post internalization. Furthermore, the polymer appears punctate around the nucleus but
not within the nucleus, which suggests that the vesicles are localized within endolysosomal
cavities. However, further investigation is required to draw a conclusion.5
V.
To investigate cellular internalization and localization o f polymer vesicles, Kamei and
coworkers co-stained different cellular organelles to determine the fate o f polymer vesicles after
internalization.6

For their study, vesicles were prepared from a copolymer composed of

polyarginine as the hydrophilic block and polyleucine as the hydrophobic block. This
composition had been shown to increase cell internalization.42 Before uptake with vesicles, the
HeLa cells were incubated with antibodies for either early endosomes or lysosomes.

After

uptake, secondary antibodies with a fluorescent tag (Cy5)-were used to visualize the different
cellular compartments. The results o f the uptake experiment can be seen in Figure 11.
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Arginine-Leucine

polymer vesicles

are

located

within

early

endosomes

after

internalization as seen by colocalization o f the polymer (green) with the endosomes(red) in
Figure 11. However, vesicles appear to avoid lysosomes. As the vesicles avoid lysosomes,
therapeutics such as proteins and siRNA that may degrade in the harsh environment of the
lysosome can be employed without worry o f premature degradation. However, the localization
o f the vesicles in early endosomes indicates that for effective delivery of therapeutics to target
cells, there must be a release mechanism built into the vesicles, such as incorporation of
biodegradable copolymers. If there is not a release mechanism, vesicles could be recycled back
to the cell surface and sent out of the cell without delivering its payload and ultimately be cleared
from the host.
As it has been shown that vesicles do not concentrate in lysosomes, Discher and
coworkers showed that their encapsulated siRNA system would trigger a biological response in
vitro.39 If vesicles concentrated in lysosmes, sensitive molecules, such as siRNA, would degrade
x

before being able to interact with other molecules in the cytosol or cellular organelles. As well,
siRNA is charged and has difficulty crossing the cell membrane. Once encapsulated the charge is
hidden from the cell membrane.

To study their system, polymer vesicles with encapsulated

siRNA designed to knockdown lamin A/C protein was compared with free siRNA, siRNA
encapsulated in liposomes (LF2k) and viral delivery (Lenti-shRNA).
Polymer vesicles with encapsulated siRNA appear to be as effective as commercially
available liposomes with encapsulated siRNA.

Furthermore, the polymer vesicle system is

visibly more effective at delivering siRNA into the cell in comparison with free siRNA.
However, commercially available viral systems are more efficient at delivering siRNA into the
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cell. This suggests that internalization is not just a passive mechanism but rather can be
influenced by surface topology o f the delivery system.
1.15 In Vivo Analysis
V

One advantage o f polymer vesicles over liposomes is their circulation time in vivo. To

increase the circulation time o f liposomes in vivo, a PEO has been conjugated to a certain
fraction o f the phospholipids comprising the vesicle;43 PEO resists protein absorption and uptake
by the reticuloendothelial system.15 Polymer vesicles that contain PEO as their hydrophilic
block circulate even longer than liposomes with PEO.

The half life o f PEO vesicles circulating

are usually in the range of 20-30 hours. Polymer vesicles with PEO as the hydrophilic block
selectvely accumulate in tumour sites to some extent via the EPR effect as described above.
i
However, this form o f targeting is not highly specific, so some systems may need a form o f
active targeting.

.

: ,

1.16 Vesicle Surface Functionalization

'•s

A common approach for vesicle functionalization is to manipulate the terminal group of
the hydrophilic block, van Hest and coworkers made copolymers with azides at their termini.44
The azide functional group can in principle react with an alkyne moiety of another molecule of
interest via a copper catalyzed “click” reaction.44 To illustrate their model van Hest and
coworkers clicked fluorescent dyes onto the surfaces o f vesicles.
While active targeting o f polymer vesicles would add another layer o f functionality,
active targeting o f polymer vesicles is a relatively new area of study. Hammer and coworkers
showed that polymer vesicles with biotin groups on their surfaces can bind to surfaces with
avidin and also to cells with avidin on their surfaces.45 Using their model, they attached other
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proteins, like antihuman IgG, to target polymer vesicles to specific cells.46 As well, Hunziker
and coworkers attached polyguancylic acid to target macrophages with upregulated SRA1
receptor.47 While these systems work

invitro, they have not been pro

1.17 Dendritic Surface Functionalization of Polymer Vesicles
In the Gillies lab, a similar approach to van Hest has been reported except that the
molecule attached to the surface of the vesicle is branched and multivalent.34 A polyester
dendron based on 2,2-bis(hydroxymethyl)propanoic acid and containing a focal point alkyne
group was synthesized and subsequently attached to the assembled vesicle surface as seen in
Figure 5. The advantage of attaching the dendron to the surface of the vesicle after assembly is
that the dendron will not interfere with the self-assembly of the vesicle. The attachment of the
branched dendron adds another hydrophilic block to the polymer and a different morphology, or
no self-assembly, could be attained if the dendron were attached before assembly.

c
*•
Block copolymers

Vesicle with activated
surface groups

----------- ►
Dendron with
complementary
focal point group

Functionalized vesicle

Figure 5. Surface functionalization of polymer vesicles with dendritic groups via click
chemistry.
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Thus far, the Gillies group has introduced dendritic groups to the surfaces o f vesicles
based on both nondegradable PBD-PEO copolymers34,18 and PCL-PEO copolymers27. Dendrons
with several peripheral functionalities such as hydroxyls, amines, and mannose molecules have
been investigated and the chemistry has proven to be versatile and reproducible. In addition,
using mannose as a model biological ligand, it was demonstrated that enhanced binding to the
protein target concanavalin A (ConA) was obtained when vesicles were functionalized on their
surfaces with dendritic mannose rather than individual molecules of mannose.

This was

hypothesized to result from increased availability o f the mannose on the vesicle surface when it
was presented on the dendrimer periphery as the dendron would reside at the vesicle surface
rather than being buried within the PEO layer. This study suggested that the dendritic scaffold
may be ideal for the display o f biological ligands in drug delivery systems. However, in this
dendritic surface functionalization work it was noted that the conjugation of high levels of
dendritic groups induced vesicle aggregation, possibly the result o f membrane destabilization
due to the branched architecture o f the dendritic group. This aspect requires further study. In
addition the encapsulation o f molecules within the vesicles was not explored ih combination with
the dendritic surface functionalization approach.
(

1.18 Cell Penetrating Agents
|

While polymer vesicles have been previously shown to enter cells in vitro and in vivo,

increasing the internalization would allow for use o f lower clinical dosage.

To increase

internalization, researchers looked to biology, and found that a protein produced by the human
immunodeficiency virus (HIV) has cell penetrating properties.49 Extensive studies have revealed
that the critical portion o f this protein, responsible for its cell penetrating properties is a 9 amino
\
'
'
acid sequence.50 This sequence contains 6 arginine residues and 2 lysine residues, suggesting that
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cationic charge is essential for increased internalization. Further research has shown that linear
sequences o f arginine residues are even more efficient at penetrating the cell membrane while
linear sequences o f lysine residues are less efficient than the native sequence, suggesting the
guanidine group on the arginine residue is required for the increased penetration observed.
Furthermore, introducing flexibility into the backbone o f the sequence further increases the
efficiency.51 A variety o f linear and multivalent displays o f guanidinium moieties have
subsequently been developed and shown to exhibit cell penetrating properties.
Utilizing the above principles, the Gillies lab developed a polyester dendron having eight
guanidine moieties at its periphery.51 This dendron is easy to prepare synthetically, is based on a
biodegradable scaffold, and was shown to have similar cell penetrating properties to the HIV49.57
peptide in vitro.51 It has also been demonstrated that conjugation o f this Dendron to
superparamagnetic iron oxide nanoparticles enhances their uptake into GL261 cells, enabling
their enhanced detection by magnetic resonance imaging.51 Furthermore, it was shown that
conjugation o f the same dendron to biodegradable micelles increases their internalization into
\
HeLa cells. While the exact mechanism o f internalization has not been elucidated, a hypothesis
o f direct internalization can be seen in Figure 6.2
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Figure 6. Postulated mechanism o f direct cell penetration of cargo conjugated to a dendron with
guanidine functional groups on the periphery.
While guanidine-rich cell penetrating agents have a demonstrated ability to efficiently
\
cross cell membranes, the concentration o f the cell penetrating agent must be moderated.
Although extensive toxicity studies have not been performed yet, initial studies suggest that like
other cationic systems, they exhibit toxicity at high concentrations. When deciding to use a cell
penetrating agent in a drug delivery system, the concentration used must not impart a toxic
response in the host since drug delivery systems are not intended to be toxic.
1.19 Thesis goals
The goal o f this thesis is to explore in more detail the effects of the dendritic surface
functionalization on both the physical and biological properties of polymer vesicles. Vesicles
based on PBD-PEO and PCL-PEO are studied and the dendrons investigated possess three
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different peripheral functionalities - neutral hydroxyls, cationic primary amines and finally
cationic guanidines. Unfunctionalized polymer vesicles are used as a control group. The effects
o f the dendrons on the release rates o f molecules from the vesicles is investigated using
rhodamine B as a model small molecule, while rhodamine B labeled bovine serum albumin
(BSA) was investigated as a model biomacromolecule. This provides insight into the effects of
the dendritic groups on the vesicle stability. The cytotoxicities of vesicles functionalized with the
different dendritic groups are evaluated using the MTT assay.

Finally, the effects o f the

peripheral functionalities of the dendritic groups on the internalization o f the vesicles in HeLa
cells are investigated by fluorescence confocal laser scanning microscopy.

s

■\

I
\
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Part Two: Results and Discussion

2.1 Synthesis
2.1.1 Synthesis of Dendrons
To test the effect o f branched surface functionality on polymer vesicles, polyester
dendrons based o f 2,2-bis(hydroxymethyl)propionic acid were selected because o f their ease of
synthesis,51 biocompatibility,27 and the fact that this dendron has been used in our previous
work.48 All o f the dendrons contained a focal point alkyne group designed to undergo a click
reaction with an azide group of the vesicle periphery as in the group’s previous work. This
dendron was synthesized by a divergent method shown in Scheme 1, involving the reaction of
alcohol groups on the dendron periphery with an anhydride derivative of the monomer
containing acetonide protecting groups on alcohols. At the third generation, the hydroxyl groups
on the periphery o f dendron 1 were reacted with a P-alanine based anhydride (Scheme 2) to
produce a dendron (2) with primary amines on the periphery after deprotection o f the Boc
groups.
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Scheme 1. Divergent synthesis o f a third generation polyester dendron.
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Scheme 2. Functionalization of a third generation dendron from hydroxyl functionality to amine
and guanidine functionality.

From the deprotected amine dendron, guanidine functionality was installed on the
periphery

by

reaction

with

N,N?-bis(BOC)-6-guanidinylcaproic

acid,

O-benzotriazole-

N,N,N’,N’-tetramethyluronium

hexafluorophosphate (HBTU) and hyHroxybenzotriazole
...................
‘
. \
(HOBt). The protected guanidine dendron was purified on a silica column by first washing with
ethyl acetate and elution off the column with a 9:1 mixture of CHaC^M eOH. After removal of

the Boc protecting group by treatment with 1:1 trifluoroacetic acid (TFA)/CH2Cl2 the guanidine
clendron 3 was obtained.
2.1.2 Synthesis of dye-labeled dendrons
To measure the degree o f functionalization o f polymer vesicles, the third generation
dendron bearing peripheral amine functional groups was reacted with a rhodamine B derivative
to give a dendron (4) with one rhodamine B unit statistically as previously reported.34 This
<
'
'
•
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dendron was used in previous work with polymer vesicles and would allow comparison between
different vesicle systems used in our group. Additionally, the guanidine functionalized dendron 5
was prepared by first reacting with the Boc protected guanidine derivative in the presence of
HBTU, HOBt, and diisopropylethylamine (DIPEA), then removing the Boc groups by treatment
with 1/1 TFA/CH2CI2 (Scheme 3). The extinction coefficients (e) for the dye labeled amine and
dye labeled guanidine dendrons were determined by UV-visible spectroscopy in order to enable
the quantification o f their conjugation yields to the surfaces o f vesicles.

Scheme 3. Synthesis o f Rhodamine labeled guanidine dendron.
2.1.3 Polym er Functionalization
Vesicles based on two different diblock copolymers were investigated in this work. One
polymer was the amphiphilic linear diblock copolymer PBD-PEO with a composition of 6500
g/mol PBD (80% 1,2-addition) and 3900 g/mol PEO, 6. Vesicles formed using closely related
polymers have been extensively investigated and found to be highly stable and biocompatible.
A terminal azide group was introduced to PBD-PEO by reaction o f the terminal hydroxyl with
azidoacetic acid to provide PBD -PEO -N 3 (7).34 The terminal azide, which should be presented
on the vesicle surface, allows for the conjugation of a dendron with an alkyne focal point by a
27

copper (I)-catalyzed 3 + 2 “ click” cycloaddition.34 The other polymers were PEO-PCL diblock
copolymer, 8, and the azide functionalized PEO-PCL, 9, which were available from another
member of the group.

2.2 Vesicle Preparation
2.2.1 Vesicle Formation
Vesicles based on PBD-PEO were prepared using a thin film rehydration method.
Commercially available PBD-PEO and azide-terminated PBD-PEO in a 4:1 mixture were
dissolved in CH2CI2. A thin film was obtained by removing the CH2CI2 under a stream of
nitrogen. Next, water was added and the resulting vesicle suspension was stirred vigorously for
0.5 hours to break up the polymer film. The suspension was then sonicated and stirred overnight
at 40 °C. Finally, the vesicle suspension was extruded at high pressure to reduce the sizes o f the
vesicles. After extrusion through a 100 nm membrane, vesicles with diameter o f approximately
160 nm, and with azide groups on their peripheries were obtained. Vesicles based on PEO-PCL
with surface azide groups were prepared by the “solvent switch” method, as previously reported,
by a member o f the group, as seen in Figure 7. 27
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Figure 7. Self-Assembly of 20% azide functionalized PBD-PEO and PEO-PCL vesicles.
2.2.2 Surface Functionalization of Vesicles with Dendritic Groups

\

With the extruded vesicles in hand, different functionalized systems can be obtained by a
click reaction using the procedure illustrated in Figure 16. Naked PBD-PEO vesicles, 10, were
used as a control group for the PBD-PEO vesicle system as they do not have any surface
modification other than the terminal azide group.

From vesicle sample 10, the surface was

modified to a neutral functionality by a reaction with 1 using click reaction conditions involving
CuCl2 and sodium ascorbate for 24 hours.

The hydroxyl functionalized vesicles, 12, were

purified by dialysis in water. For cationic functionalized vesicles, vesicle sample 10 was mixed
with 2 under click conditions. After 24 hours, amine functionalized vesicles, 13, were purified
by dialysis in water. The same procedure was used to produce guanidine functionalized vesicles
29

14. Another member of the group prepared vesicle sample 11 as previously reported.

From

vesicle sample 11, hydroxyl functionalized vesicles, 15, were obtained by reaction with the
hydroxyl functionalized dendron 1 under click conditions.

The functionalized vesicles were

purified by dialysis in water.

Scheme 3. Surface functionalization of polymer vesicles via click reaction.
The Z-average diameter of vesicle sample 10 was 160 nm with a polydispersity index
(PDI) of 0.15, as shown in Figure 8. The bimodal size distribution indicates that there were two
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different populations within the sample, the first being approximately 60 nm in diameter and the
second being approximately 180 nm diameter. However, as the second population is three times
the size as the first, it is possible that the second population is an aggregate o f a few smaller
vesicles.

Figure 8. Size distribution of vesicle sample 10 expressed as a volume fraction.
\
The Z-average diameter of vesicle sample 12 was 170 nm with a pdi of 0.17, as shown in
/ Figure 9. The bimodal distribution again indicates that there were 2 different populations within
the sample, the first being approximately 75 nm in diameter and the second being approximately
220 nm in diameter. Again, it is likely that the larger population is aggregates o f individual
vesicles. The increased size o f the vesicles and aggregates can be attributed to the addition of the
dendrons, which may lead to a thicker vesicle membrane. The Z-average diameter of vesicle
sample 13 was 180 nm with a PDI o f 0.16, as seen in Figure 10.

Again, a bimodal size

distribution was obtained, likely due to aggregation, and the vesicles were larger than the
unfunctionalized vesicles. The Z-average diameter o f vesicle sample 14 is 200 nm with PDI of
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0.24, as seen in Figure 11. Unlike with previous samples, vesicle sample 14 did not have a
distinctively bimodal size distribution. However, the peak is not symmetric as there is a shoulder
around 95 nm indicating this was likely just due to the inability o f the instrument to resolve the
two size populations.

Figure 9. Size distribution o f vesicle sample 12 expressed as a volume fraction.

Figure 10. Size distribution o f vesicle sample 13 expressed as a volume fraction.
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Figure 11. Size distribution of vesicle sample 14 expressed as a volume fraction.
The Z-average diameter of vesicle sample 11 is 120 nm with a PDI o f 0.08, as shown in
Figure 12. Unlike with the PBD-PEO samples, the peak is monomodal, indicating that a single
population o f particles exists in the sample. Furthermore, as the size distribution is monomodal,
the pdi is lower than those obtained for the functionalized vesicles derivedvfrom vesicle sample
\

,

10. The Z-average diameter of vesicle sample 15 is 140 nm with a pdi o f 0.15, (Figure 13). As
with vesicle sample 11, the size distribution is monomodal indicating that a single population
exists within the sample. As seen in the PBD-PEO samples, the minor size increase is expected
since functionalization with the hydroxyl dendron increases the thickness o f the vesicle
membrane.

As we have reported, functionalization o f vesicle sample 11 with the cationic

dendrons results in samples that form large aggregates.

The aggregation is so extensive that the

vesicles are no longer dispersible in water and precipitate out o f solution even at an azide loading
below 20%. As a result, these samples were not tested further.
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Figure 2. Size distribution of vesicle sample 11 expressed as a volume fraction.

Figure 3. Size distribution o f vesicle sample 15 expressed as a volume fraction.

described above, but using the dye labeled dendrons 4, and 5. Following the removal of the
excess dendron by dialysis and then evaporation o f the water, the materials resulting from each
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reaction were dissolved in CHC^rMeOH (3:2), and their UV-visible absorbances were
measured. Using the

e

of the dye labeled dendrons, which were previously measured, the yields

o f the dendron conjugated to the vesicle surfaces were then calculated.

The conjugation

efficiency o f the two dendrons to vesicle sample 10 can be seen in Table 1 along with previously
reported values for PEO-PCL vesicles from our lab. It should be noted that although the
conjugation yields were not measured for the dendron with hydroxyl groups on the periphery due
to the challenges associated with preparing a dye-labeled dendron, they can be inferred to be
similar or slightly greater than those obtained with the amine functionalized dendron.
Table 1. Conjugation efficiency o f amine and guanidine dendrons to the surface o f polymer
vesicles.

System

PBD-PEO Vesicles

PEO-PCL Vesicles^7

Amine Dendron

48%

58%

Guanidine Dendron

37%

41%

The conjugation yields for the vesicles composed o f different copolymers were similar.
As the polymer forms a bilayer structure, only half o f the azide groups are displayed on the
exterior o f the vesicle surface. The theoretical yield is around 50% as the dendron would not be
expected to readily diffuse through the vesicle membrane because o f its large size and cationic
charge.

However, as previously argued34 the vesicle membrane is dynamic and individual

polymer strands may flip orientation from the interior o f the vesicle to the exterior o f the vesicle.
This characteristic o f polymer vesicles would allow for yields greater than 50%, which are
reported for lower azide loadings. Furthermore, the conjugation o f dendron 5 has a lower yield
for both the PBD-PEO and PEO-PCL systems. This is expected as the guanidine dendron is
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larger than the amine dendron and sterics on the vesicle surface would inhibit conjugation o f the
dendron.
•'
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2.3 Encapsulation and Release of Small Molecules and Proteins
The study o f the encapsulation and release o f molecules from the dendron functionalized
vesicles is o f interest for several reasons. First, as destabilization or disruption o f the vesicles
would likely result in the release o f encapsulated molecules, the release rates o f these molecules
may provide insight into how the introduction o f the different dendrons to the vesicles surfaces
affects the stability o f the resulting vesicles. In addition, if these materials are to be used for drug
delivery applications, it is important to gain insight into their release kinetics. In this work the
release o f both small molecules and macromolecules was investigated. Small molecules might be
expected to diffuse across the vesicle membrane or be released upon vesicle disruption. Thus the
release rate o f small molecules would provide insight into vesicle stability as well as membrane
permeability. On the other hand, macromolecules would not be expected to readily diffuse across
the vesicle membrane and thus vesicles would likely have to be disrupted to release the
\

molecules.
2.3.1 Encapsulation and Release of Rhodamine B
To measure the rate of release o f encapsulated small hydrophilic molecules, a fluorescent

j rhodamine B was chosen as a model compound. It was selected as it is highly absorbant and
fluorescent, thus enabling ready detection o f its release. In order to encapsulate it, vesicles were
formed as above but in a rhodamine B solution, the click reactions were performed to introduce
the dendrons, the vesicles were extruded, and finally the nonencapsulated rhodamine B was
removed by rapid dialysis using a Slide-a-lyzer dialysis cassette. In order to determine when the
nonencapsulated dye had completely diffused across the dialysis membrane, a control dialysis
36

containing rhodamine B in the same concentration as used to form the vesicles was run at the
same time as the vesicle solutions, and when the dye had left the cassette in the control group,
the release experiment began. PEO-PCL vesicles were prepared as above except rhodamine B
was dissolved in the water added to the copolymer during vesicle formation. The free rhodamine
B was removed as in the PBD-PEO vesicle method. With the loaded vesicles in hand, the
dialysis water was replaced with 0.1 M phosphate buffer water containing 0.01M sodium azide at
37°C. Every hour an aliquot was taken from the dialysate and its fluorescence was measured to
determine the extent o f release.
The release o f encapsulated rhodamine B from vesicle sample 10 can be seen in Figure
14. The data was fit to a first order release model for a sphere with a polymeric exterior where
percent release = Mi + M2*(l-exp(-M3*t)). In the equation, Mi corresponds to percent release at
time zero, M2 corresponds to maximum release, M3 is dependent on diffusivity o f the dye
through the polymer membrane, and t is time in hours. The first order release model was found
to best fit the data in comparison to other models, and corresponds to encapsulated rhodamine B
■
.
...
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diffusing through the vesicle membrane. The Mi, M2 and M3 values o f the curve fit can be seen
in Table 2 along with R values and error. For vesicle sample 10, a value o f -5.4 was obtained for
Mi, 100 for M2 and 0.17 for M3. Furthermore, the R value o f the fit is 0.95, indicating that there
is a good fit to the release profile. While none o f the data points had a negative percent release
value, allowing the Mi values be less than zero a better fit to the data could be obtained. This
could indicate that some nonencapsulated rhodamine B was still present within the dialysis
cassette at t = 0. For vesicle sample 12 (Figure 15), a value o f -0.057 was obtained for Mi, 85
for M2 and 0.36 for M3. As well, the R value o f the fit is 0.93 indicating that there is a good fit
to the release profile. The M3 value is more than double the value obtained for vesicle sample 10
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suggesting that there is a change in the diffusivity o f the dye. This suggests that the presence of
the dendritic groups may destabilize the polymer bilayer to some extent, allowing the dye to
more readily diffuse across the vesicle membrane.” For vesicle sample 13 (Figure 16), a value of
2.3 was obtained for M i, 83 for M2 and 0.45 for M3 .

As well, the R value of the fit is 0.94

indicating that there is a good fit to the release profile. In this case, the M3 value is 0.45. This
suggests that the dendron on the surface alters the diffusivity o f the dye through the membrane.
Furthermore, m 3 is larger than that o f vesicle sample 12 which could be attributed to the positive
charge of the dendron periphery which leads to some additional vesicle destabilization. For
vesicle sample 14 (Figure 17), a value o f 0.74 was obtained for Mi, 96 for M2 and 0.34 for M3 .
As well, the R value of the fit is 0.94 indicating that there is a good fit to the release profile. The
presence o f the guanidine functionality results in similar result as seen with vesicle sample 12
and vesicle sample 13 but the value for M3 is similar to vesicle sample 12 and not vesicle sample
13 which disproves that the positive charge results in a greater diffusivity as compared to neutral
functionality on the dendron periphery. Furthermore, it appears that the dendron architecture is
responsible for the change in release rate relative to the unfunctionalized ^system and not the
functionality on the periphery of the dendron. For vesicle sample 11 (Figure 18), a value o f 6.9
was obtained for M i, 86 for M2 and 0.13 for M3 .
indicating that there is a strong fit to the release profile.

As well, the R value o f the fit is 0.94
Interestingly, the mathematic model is

The same for both the PBD-PEO systems and the PEO-PCL systems and the Mi, M2 and M3
values are similar to vesicle sample 10. This indicates that the hydrophobic block composition
does not change the mechanism o f release o f encapsulated small molecules.

'\
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Figure 4. Release o f encapsulated rhodamine B expressed as percent released from vesicle
sample 10. The data was fit to a first-order model.
•

\

Table 2. Coefficients o f curve-fit from Kaleida Graph 4.0 for a first-order model.
Sample #

Mi

m

10

-5.4 ± 4.3

12

m3

R value

100 ± 4.3

0.17 ± 0.02

0.96

-0.057 ±5.1

85 ±5.1

0.36 ± 0.04

0.93

13

2.3 ± 4.7

83 ± 4 .7

0.46 ± 0.05

0.94

14

0.74 ± 4 .8

96 ± 4.8

0.34 ± 0.04

0.94

11

6.9 ± 4.6

84 ± 5 .7

0.13 ± 0.02

0.95

2
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Figure 5. Release o f encapsulated rhodamine B expressed as percent released from vesicle
sample 12. The data was fit to a first-order model.

Figure 6. Release o f encapsulated rhodamine B expressed as percent released from vesicle
v.

sample 13. The data was fit to a first-order model.
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Figure 7. Release o f encapsulated rhodamine B expressed as percent released from vesicle
sample 14. Tlie data was fit to a first-order model.

Figure 8. Release o f encapsulated rhodamine B expressed as percent released from vesicle
sample 11. The data was fit to a first-order model.
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2.3.2 Encapsulation and Release of Rhodamine labeled BSA
To test the change in rate o f release o f encapsulated macromolecules, vesicles were
formed in the presence o f a fluorescently labeled protein, followed by click reactions installing
different surface functionalities. Rhodamine B labeled BSA was selected as a model since it has
a high solubility in water, high molecular weight, and its fluorescence properties would easily
allow quantification o f its release rate. A vesicle solution was prepared as above except with
r

rhodamine B labeled BSA dissolved in the water added to the thin film ., The vesicle solution was
then extruded and nonencapsulated BSA was removed by dialysis. Again a control experiment
was run in order to determine the length o f time required for the free protein to diffuse across the
dialysis membrane. PEO-PCL vesicles with encapsulated protein were prepared by dissolving
the protein in the .water that was added to the dissolved copolymer during vesicle formation. The
non-encapsulated protein was removed in the same manner as for the PBD-PEO vesicles.
With the protein-loaded vesicles in hand, the dialysis water was replaced with 0.1 M
phosphate buffer water containing 0.01 M sodium azide at 37 °C. Each day the protein release
was evaluated by fluorescence measurements.

\

The release o f encapsulated protein from vesicle sample 10 can be seen in Figure 19.
The data was fit to a power-law model for a sphere with a polymeric exterior where percent
¡release = M4 + Ms*tAM6. In the equation, M4 corresponds to percent release at time zero, M5 is
dependent on the diffusion rate o f the protein out o f the vesicle, M6 is the diffusion coefficient
and t is time in days. Proteins are larger molecules and would have difficulty diffusing through
the hydrophobic region o f the polymer membrane which suggests a different mechanism of
release for encapsulated proteins. The power-law model corresponds to encapsulated rhodamine
labeled BSA diffusing through temporary pores which form in the vesicle membrane. The
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protein still diffuses down its concentration gradient. The M4, M5 and M6 values of the curve fit
can be seen in Table 3 along with R values and error. This equation can only be used to model
the initial phase o f the release; as t approaches 00, percent release would also approach 00.
However percent release cannot exceed 100% and as a result, another mathematic model is
needed to describe release approaching 100% release.

This was not an issue in these

experiments because none o f the samples reached 100% release. As with small molecule release,
none o f the data points had a negative percent release value however by allowing M4 be less than
zero, a stronger fit to the data could be obtained. For vesicle sample 10, a value of 2.8 was
obtained for M4, 33 for M5 and 0.35 for Mg.

Furthermore, the R value o f the fit is 0.95,

indicating that there is a good fit to the release profile. For vesicle sample 12 (Figure 20), a
value o f -0.63 was obtained for M4, 52 for M5 and 0.24 for Mg. As well, the R value o f the fit is
0.97 indicating that there is a good fit to the release profile. The Mg value is less than the value
obtained for vesicle sample 10 suggesting that there is a change in the diffusivity of the protein.
For vesicle sample 13 (Figure 21), a value o f 0.70 was obtained for M4, 25 for M5 and 0.44 for
Mg. As well, the R value o f the fit is 0.97 indicating that there is a good fit to \h e release profile.
y

1

.

In this case, the Mg value is 0.44. This suggests that the dendron on the surface alters the
diffusivity o f the dye through the membrane. Furthermore, Mg is larger than that o f vesicle
sample 12, which could be attributed to the positive charge o f the dendron periphery that leads to
'I
some additional vesicle destabilization. For vesicle sample 14 (Figure 22), a value o f 4.0 was
obtained for M4, 22 for M5 and 0.48 for Mg.

As well, the R value o f the fit is 0.95 indicating

that there is a good fit to the release profile. The presence o f the guanidine functionality results in
a similar result as seen with vesicle sample 13 suggesting the positive charge results in a greater
diffusivity as compared to neutral functionality on the dendron periphery. For vesicle sample 11
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(Figure 23), a value o f 2.9 was obtained for M4, 33 for M5 and 0.34 for M6. As well, the R value
o f the fit is 0.96 indicating that there is a strong fit to the release profile.

As with encapsulated

small molecules, the mathematic model is the same for both the PBD-PEO systems and the PEOPCL systems and the M4, M5 and M6 values are similar to vesicle sample 10. This indicates that
the hydrophobic block composition does not change the mechanism of release o f encapsulated
proteins.

Table 3. Coefficients o f curve-fit from Kaleida Graph 4.0 for a power law model.

Sample #

m

10

2.8 ± 7.2

33 ± 7 .6

12

-0.63 ± 5.8

52 ± 6.4

4

M5

m

44

•

6

R value

0.35 ± 0.07

0.95

0.24 ± 0.04

0.97

13

0.70 ± 5 .0

25 ± 5.0

0.44 ± 0.07

0.97

14

4.0 ± 6 . 9 .

22 ± 6.8

0.48 ± 0.10

0.95

11

2.9 ± 6.1

33 ±6. 2

0.34 ± 0.05

0.96

Figure 10. Release o f encapsulated rhodamine labeled BSA expressed as percent released from
vesicle sample 12. The data was fit to a power-law model.

r
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Figure 111. Release o f encapsulated rhodamine labeled BSA expressed as percent released from
vesicle sample 13. The data was fit to a power-law model.

Figure 12. Release o f encapsulated rhodamine labeled BSA expressed as percent released from
vesicle sample 14. The data was fit to a power-law model.
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Figure 13., Release o f encapsulated rhodamine labeled BSA expressed as percent released from
vesicle sample 11. The data was fit to a power-law model.
2.4 Cell V iability
To assess the effect the polymer vesicles had on the viability o f cells, the toxicity profile
o f the different systems was measured using the MTT assay. HeLa cells Were selected as a
V
commonly used cancer cell line and the .vesicles were evaluated at concentrations ranging from
0.0078 mg/mL to 1 mg/mL As shown in Figure 24, the toxicity profile for, vesicle sample 10
indicates that the presence unfunctionalized polymer vesicles does not affect the metabolic
activity o f cells. The lack o f toxicity makes vesicle sample 10 a good reference point to compare
the different surface functionalities for viability.

t
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Polymer C oncentration (mg/mL)

Figure 14. Toxicity profile of vesicle sample 10 as measured by the MTT assay. Error bars
represent 1 standard deviation from the mean.
The toxicity profile for vesicle sample 12 is shown in Figure 25. The neutral hydroxyl

(1

L

functionality does not impart a toxic response at any of the concentrations tested, as the cell
I

viability remains the same as that of control cells not exposed to vesicles. As shown in Figure 26,
I

the amine functionality on the vesicle surface of vesicle sample 13 begins to induce toxicity at
the highest concentrations tested, likely due to its cationic charge. 52 The toxicity profile for
vesicle sample 14 is shown in Figure 27. At lower concentrations, the guanidine functionality
does not affect the metabolic activity of cells. At the highest concentration, metabolic activity is
below 60%. Its toxicity is greater than that of the amine functionality, indicating that cationic
charge is not the only factor resulting in the toxic effect. This result is consistent with previous
work since it has been reported that dendritic guanidine functionality imparts greater toxicity
than primary amine functionality. ’

Nevertheless, at low concentrations, the guanidine
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functionalized vesicles did not exhibit toxicity, indicating that they can still potentially be used to
transport molecules into living cells.

140

Cl.

Polymer C oncentration (mg/mL)

Figure 15. Toxicity profile of vesicle sample 12 as measured by the MTT assay. Error bars
represent 1 standard deviation from the mean.

120

Polymer Concentration (mg/mL)

Figure 16.

Toxicity profile vesicle sample 13 as measured by the MTT assay.

represent 1 standard deviation from the mean.
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Error bars

120

Polymer Concentration (mg/mL)

Figure 17.

Toxicity profile of vesicle sample 14 as measured by the MTT assay. Error bars

represent 1 standard deviation from the mean.
The toxicity profile of the PEO-PCL systems 11 and 15 is shown in Figure 28. The
unfunctionalized vesicles 11 appear to be toxic as visibly lower viability values are observed
relative to the PBD-PEO system and to vesicle sample 15. While this trend is not expected since
PCL-PEO is generally considered to be biocompatible, it was obtained on repeated attempts at
this assay. There are many variables that could cause lower viability such as contamination in
the copolymer or residual organic solvent remaining after purification. Unlike vesicle sample
11, vesicle sample 15 follows a trend similar to its PBD-PEO counterpart except with some
toxicity observed at the highest concentration.

50

Percent Viability

120

■ ll
■ 15

0.0078

0.016

0.031

0.063

0.13

0.25

0.50

1.0

Polymer Concentration (rag/mL)

Figure 18. Toxicity profile of vesicle sample 11 and vesicle sample 15 as measured by the MTT
assay. Error bars represent 1 standard deviation from the mean.
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2.5 Cell Uptake
While it has been previously shown that nanoparticles that have been functionalized with
dendrons do enter cells,51 a comprehensive investigation has not been completed and the effects
of the dendritic groups on the cell uptake o f PBD-PEO or PEO-PCL vesicles have not yet been
studied.

To measure the cell internalization of the different systems, functionalized vesicle

systems were prepared as above except containing 1% rhodamine B functionalized copolymer to
allow visualization o f the vesicles using fluorescence microscopy.

Furthermore, since

fluorescence is quantitative, this allows for the quantification of the amount of polymer within
the cells. HeLa cells were used in these studies and the cell uptake of the different vesicles was
examined both qualitatively and quantitatively following 1 hour incubations at 37 °C. The cell
nuclei were stained with DAPI.54
As shown in Figure 29, after 1 hour incubation at 37 °C, in each case, the fluorescence
did not appear to be specifically located in the nuclei but rather throughout the cytoplasm. Its
somewhat punctate nature suggests that the polymers may be located within endosomal or
lysosomal compartments, but further staining experiments are required to confirm this. The
intensity of the fluorescence in the images corresponds to the amount of material in each since
the images were captured under the same conditions and the concentration of dye remained
constant throughout the experiment. While vesicle samples 10, 12 and 13 appear to have similar
intensity, vesicle sample 14 appears to contain more polymer material, likely due to the
guanidine group on the periphery since a similar result is not seen in vesicle sample 13.
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Figure 19. Confocal Microscope image of HeLa cells incubated with vesicle samples 10 (top
left), 12 (top right), 13 (bottom left) and 14 (bottom right) at a concentration of 0.25 mg/mL with
1% rhodamine B dye labeled polymer. DAPI is seen in blue and rhodamine in red.
To obtain a quantitative result, the captured images were analyzed in Imagepro to
measure the fluorescence intensities. The average relative intensity per cell for each sample can
be seen in Figure 30. Vesicle samples 10, 12, 13 and 14 did exhibit statistically significant
differences in fluorescent intensities as determined by a one way ANOVA test. However with
further analysis using Post Hoc Tukey’s Honestly Significant Difference (HSD) test and
Scheffe’s method, no significant difference was found between 10, 12 and 13. For Tukey’s
HSD, p-values obtained for vesicle samples 10 and 12, 10 and 13, and 12 and 13 were 0.53, 0.18
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and 0.89 respectively. For Scheffe’s method p-values of 0.61, 0.25 and 0.91 respectively were
obtained. In contrast, consistent with the visibly greater fluorescence in Figure 28, vesicle sample
14 did have significantly greater uptake confirmed by Tukey’s HSD and Scheffe’s method
because a p-value of less than 0.001 was obtained for each comparison. Thus, the presence of
guanidine functionalities does seem to specifically enhance cell uptake, a result that was not
obtained for vesicles functionalized with the dendron having cationic amine groups.

350000 -,

Sample

Figure 20.

Intensity analysis of vesicle samples 10, 12, 13 and 14. Error bars represent one

standard deviation from the mean.
The internalized vesicle samples 11 and 15 as seen in Figure 31, similar to PBD-PEO
vesicles at 37°C appear to be punctate throughout the cytoplasm of the cell. The PCL-PEO
systems had aggregation issues, larger aggregates not internalized by cells were excluded from
the counting algorithm as well as possible.
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Figure 21. Confocal Microscope image of HeLa cells incubated with vesicle samples 11 (left)
and 15 (right) at a concentration of 0.25 mg/mL with 1% rhodamine B dye labeled polymer.
DAPI is seen in blue and rhodamine in red.
As with the PBD-PEO samples, captured images of vesicle samples 11 and 15 were
analyzed using Imagepro. Interestingly, vesicle sample 11 did exhibit significantly increased cell
uptake relative to vesicle sample 15 (t-test, p < 0.005), as seen in Figure 32, this could be due to
aggregation issues of vesicle sample 15 since aggregated samples would be less likely to enter
cells because of their larger diameter.
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Figure 22. Intensity analysis of vesicle samples 11 and 15.
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Part Three: Conclusion

V
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3.1 C onclusion

Polymer vesicles based on PBD-PEO and PCL-PEO were studied and dendrons
possessing three different peripheral functionalities - neutral hydroxyls, cationic primary amines
and finally cationic guanidines were investigated. The conjugation efficiencies o f the cationic
dendrons to the PBD-PEO vesicle surfaces were measured and the efficiencies were found to be
similar to those o f the previously reported reactions onto the surface o f PEO-PCL vesicles.
Next, the effects o f the dendrons on the release o f encapsulated small molecules from the
•)

vesicles was investigated using free rhodamine B as a model small molecule. The presence o f ,
the dendron architecture is likely responsible for the increase in release rate since all three
functionalized systems had a similar rate increases. As well, the release rates were measured for
encapsulated proteins. Unlike with the encapsulated small molecule, the functionality of the
dendron does effect the release rate since the amine and guanidine both exhibited a quicker
release profile. This suggests that the cationic charge could destabilize the vesicle structure.
Next, the cytotoxicities of vesicles functionalized with the different dendritic groups were
evaluated using the MTT assay. Cationic functionalities, more evident in the ghanidine sample,
1(_
■ v
produced a toxic response at higher concentrations but not at lower concentrations. Finally, the
effects o f the peripheral functionalities o f the dendritic groups on the internalization of the
vesicles in HeLa cells was measured by fluorescence confocal laser scanning microscopy. It was
found that the guanidine functionalized vesicles resulted in increased internalization as compared
to the other dendrons and control group. The images were analyzed using Imagepro software to
quantify the relative degrees o f internalization.

It was found that the guanidine sample was

statistically higher than the control group indicating that guanidine dendron does increase the cell

58

uptake o f vesicles. This suggests that these materials may be useful for the transport of cargo into
living cells.

)

\

I(
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Part Four: Experimental

60

4.1 Experimental
Chemicals were purchased from Sigma-Aldrich and were used •without further purification
unless otherwise noted. Dialyses were performed using Spectra/Por regenerated cellulose
membranes with either a 12000-14000 g/mol (Spectra/Por) or 3500 g/mol molecular weight
cutoff (MWCO) cassettes. UV-visible absorption spectroscopy was performed on a Varian Cary
300 Bio UV-Visible Spectrophotometer. Extinction coefficients (s) o f compounds were obtained
from calibration curves based on the measurement o f UV-visible absorbance versus
concentration in CHCL/MeOH (3/2). Dynamic light scattering (DLS) data were obtained using a
Zetasizer Nano ZS instrument from Malvern Instruments. Compounds 1-9 were prepared as
previously reported.27,34,51 Spectral data agreed with those previously reported.

4.2 General Procedure for the Preparation of PEO-PBD Vesicles
Commercial block copolymer (4 equiv.) and azide-terminated polymer 7 (1 equiv.) were
dissolved in CH2CI2. The solvent was removed under a stream o f nitrogen to produce a thin
film. Deionized (DI) water (lmL/10mg o f polymer) was added and the solution was stirred for
0.5 hours at 45 °C. The solution was then sonicated for 0.5 hours and finally stirred for 24 hours
at 45 °C. The vesicles were extruded 2 times through each o f 1000 nm, 400 nm, 200 nm and 100
nm polycarbonate membranes at 45 °C using a pressure driven Lipex Thermobarrel Extruder
](1.5mL capacity, Northern Lipids) unless otherwise noted.

4.3 General Procedure for the Preparation of PEO-PCL Vesicles

The block copolymer 8 (4 equiv.) and 9 (1 equiv.) was dissolved in tetrahydrofuran (THF) (0.5
mL).

DI water (2 mL) was added dropwise over 10 min with vigorous stirring. After the

addition was complete, the resulting nanoassembly suspension was stirred for 10 min. and then
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dialyzed against 2 L of DI water, using a 12,000-14,000 MWCO dialysis membrane, changing
the dialysate approximately every 12 hours for 36 hours to remove THF.

4.4 General Procedure for Surface Functionalization of Vesicles
Vesicles were prepared as described above. To the assemblies were added CuCl2-2H20 (0.40
equiv. relative to azide terminated polymer), sodium ascorbate (4.0 equiv. relative to azide
terminated polymer), and dendron in sequence and .the reaction mixture was stirred at room
temperature for 18 hours and then dialyzed against distilled water for 24 hours using a 1200014000 MWCO dialysis membrane.

4.5 Quantification of Surface Dendritic Groups
Following dialysis o f the dendron functionalized vesicles prepared as described above, the
samples were lyophilized in order to remove water and were then taken up in 2 mL o f
CHCls/methanol 3/2. The solutions were centrifuged at 4500 rpm for 4 hours to remove any
insoluble material. Finally, the absorbance was measured at' 563. nm. The degree of
functionalization was calculated using the measured e for the dye-labeled dendrons 4 or 5.

4.6 Encapsulation and Release of Small Molecules from Vesicles
Functionalized vesicles were prepared as described above, except rhodamine B (64mg) was
|

dissolved in the water used for vesicle formation. In addition, the vesicle solution was extruded
twice through only a 1000 nm polycarbonate membrane.

After functionalization, different

vesicle solutions were diluted to a concentration o f 1 mg/mL o f polymer, and dialysis was
performed using a Slide-a-lyzer dialysis cassette with a MWCO o f 3500 g/mol.

A control

dialysis containing rhodamine B in the same concentration within the dialysis cassette was
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performed at the same time as the vesicle solution. When the dye had left the cassette in the
control group, the release experiment was started (time = 0). The water was replaced with 0.1 .M
phosphate buffer water containing 0.01 M sodium azide at 37 °C. Every hour, 1 mL o f the buffer
from outside of the cassette was taken and the volume was topped up to maintain a continuous
volume o f 2 L. After 44 hours, the individual vesicle solutions were mixed with THF to disrupt
the vesicles and release the free dye. The THF was removed under reduced pressure and the
t.'

aqueous solution was returned to the dialysis cassette and allowed to stir for 24 hours. 1 mL of
water from outside was taken as a 100% release standard for each trial.

The fluorescence

intensity o f each sample was measured and compared to the 100% release sample to obtain the
percent release at a given time point.

4.7 Encapsulation and Release of Protein from Vesicles
Functionalized vesicles were prepared as described above except rhodamine B labeled BSA
(30mg) was dissolved in the water used for vesicle formation. In addition, the vesicle solution
\
was extruded twice only through a 1000 nm polycarbonate membrane. After functionalization,
different vesicle solutions were diluted to a polymer concentration o f 1 mg/mL and dialysis was
performed using a dialysis cassette with a MWCO o f 300 kg/mol.

A control experiment

containing free rhodamine B labeled BSA in the same concentration was performed at the same
Time as the vesicle solutions. When the protein had left the cassette in the control group, the
release experiment was started (time = 0). The water was replaced with 0.1 M phosphate buffer
water containing 0.01 M sodium azide at 37°C. The vesicle solution was removed from the
cassette and its fluorescence intensity was measured relative to a control o f free rhodamine B
labeled protein in solution. Each day the fluorescence intensity o f the vesicle solutions in the
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cassettes were taken relative to the free rhodamine B labeled protein solution, the volume of
water was continuously maintained at 2L. After 15 days, the individual vesicle solutions were
mixed with THF to disrupt the vesicles and release the free protein. The THF was removed
under reduced pressure and the aqueous solution was returned to the dialysis cassette and
allowed to stir for 24 hours.

The fluorescence intensity o f the aqueous samples were taken

relative to the free rhodamine B labeled protein solution to determine the complete release value.
4.8 Procedure for MTT assay
HeLa cells were cultured in Dulbecco’s Modified Eagle Medium (Invitrogen) supplemented with
10% fetal bovine serum (Invitrogen) at 37°C in an atmosphere containing 5% CO2. Viability
was measured using an MTT assay.55 Cells were seeded into a 96-well plate (Nunclon TC
treated) at a density o f 4 x l0 3 cells per well in growth medium with a final volume o f 100 pL.
The cells were allowed to adhere for 24 hours and then the medium was aspirated. To the cells,
polymer vesicle samples were added at concentrations ranging from 1.0 mg/mL to 0.0078 mg/ml
‘s,

in 100 pL o f growth medium. 8 replicates were performed for each concentration and to control
\
cells only growth medium was added. The cells were incubated for 48 hours. The media was
aspirated, then 100 pL o f fresh media and 10 pL o f MTT solution (5mg/mL) was added to each
well and incubated for another 4 hours. Media was aspirated and the formazan product was
solubilized by addition o f 50 pL DMSO to each well. Absorbance o f each well was measured at

I

540 nm using a plate reader (Tecan Safire).

4.9 Cell Uptake
HeLa cells were maintained at 37 °C and 5% CO2 in Dulbecco’s Modified Eagle Medium
(Invitrogen) supplemented with 10% fetal bovine serum (Invitrogen). Sterilized microscope glass
64

cover slips (circular 25mm diameter) were placed in the wells o f a 6-well plate and 5 x 105 cells
were seeded onto each cover slip. The cells were allowed to adhere for 24 hours. The culture
medium was then aspirated and replaced with fresh serum-free medium containing control or
functionalized vesicles at a concentration o f 0.25 mg/mL o f polymer. The experiments were
completed in triplicate. The cells were incubated at 37 °C for 1 hour. They were then washed
three times with phosphate-buffered saline (PBS) then fixed with 4% paraformaldehyde solution
for 10 min. The cells were washed again with PBS, and then treated with 2 mL o f acetone at -20
°C for 5 minutes. The cells were washed again with PBS and stained with DAPI following the
manufacturer’s directions. The cells were washed again with PBS and then were placed face
down onto microscope slides for confocal microscopy. Confocal images were obtained using a
confocal laser scanning microscope (LSM 510, Carl Zeiss) using a 63x (N.A. % 1.4) oil
immersion objective and an excitation wavelength o f 405 and 543 nm (He-Ne laser).

V
V
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